<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36499711</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>23</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>06</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Pharmacological Mechanism of NRICM101 for COVID-19 Treatments by Combined Network Pharmacology and Pharmacodynamics.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">15385</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232315385</ELocationID><Abstract><AbstractText>Symptom treatments for Coronavirus disease 2019 (COVID-19) infection and Long COVID are one of the most critical issues of the pandemic era. In light of the lack of standardized medications for treating COVID-19 symptoms, traditional Chinese medicine (TCM) has emerged as a potentially viable strategy based on numerous studies and clinical manifestations. Taiwan Chingguan Yihau (NRICM101), a TCM designed based on a medicinal formula with a long history of almost 500 years, has demonstrated its antiviral properties through clinical studies, yet the pharmacogenomic knowledge for this formula remains unclear. The molecular mechanism of NRICM101 was systematically analyzed by using exploratory bioinformatics and pharmacodynamics (PD) approaches. Results showed that there were 434 common interactions found between NRICM101 and COVID-19 related genes/proteins. For the network pharmacology of the NRICM101, the 434 common interacting genes/proteins had the highest associations with the interleukin (IL)-17 signaling pathway in the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. Moreover, the tumor necrosis factor (TNF) was found to have the highest association with the 30 most frequently curated NRICM101 chemicals. Disease analyses also revealed that the most relevant diseases with COVID-19 infections were pathology, followed by cancer, digestive system disease, and cardiovascular disease. The 30 most frequently curated human genes and 2 microRNAs identified in this study could also be used as molecular biomarkers or therapeutic options for COVID-19 treatments. In addition, dose-response profiles of NRICM101 doses and IL-6 or TNF-&#x3b1; expressions in cell cultures of murine alveolar macrophages were constructed to provide pharmacodynamic (PD) information of NRICM101. The prevalent use of NRICM101 for standardized treatments to attenuate common residual syndromes or chronic sequelae of COVID-19 were also revealed for post-pandemic future.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sher</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Life Science, School of Life Science, College of Science, National Taiwan Normal University, Taipei 11677, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Ying-Fei</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Bioenvironmental Systems Engineering, National Taiwan University, Taipei 10617, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004365">Drugs, Chinese Herbal</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000093485" MajorTopicYN="N">COVID-19 Drug Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000091484" MajorTopicYN="N">Network Pharmacology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008516" MajorTopicYN="N">Medicine, Chinese Traditional</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004365" MajorTopicYN="Y">Drugs, Chinese Herbal</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NRICM101</Keyword><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">pharmacodynamics</Keyword><Keyword MajorTopicYN="N">pharmacogenomics</Keyword><Keyword MajorTopicYN="N">protein&#x2013;protein interaction</Keyword><Keyword MajorTopicYN="N">traditional Chinese medicine</Keyword></KeywordList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>11</Day><Hour>1</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36499711</ArticleId><ArticleId IdType="pmc">PMC9740625</ArticleId><ArticleId IdType="doi">10.3390/ijms232315385</ArticleId><ArticleId IdType="pii">ijms232315385</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A., Nirantharakumar K., Hughes S., Myles P., Williams T., Gokhale K.M., Taverner T., Chandan J.S., Brown K., Simms-Williams N., et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown K., Yahyouche A., Haroon S., Camaradou J., Turner G. Long COVID and self-management. Lancet. 2022;399:355. doi: 10.1016/S0140-6736(21)02798-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02798-7</ArticleId><ArticleId IdType="pmc">PMC8776283</ArticleId><ArticleId IdType="pubmed">35065779</ArticleId></ArticleIdList></Reference><Reference><Citation>Fricke-Galindo I., Falf&#xe1;n-Valencia R. Pharmacogenetics Approach for the Improvement of COVID-19 Treatment. Viruses. 2021;13:413. doi: 10.3390/v13030413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13030413</ArticleId><ArticleId IdType="pmc">PMC7998786</ArticleId><ArticleId IdType="pubmed">33807592</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Huang W., Ma J., Liu L. SWOT analysis and revelation in traditional Chinese medicine internationalization. Chin. Med. 2018;13:5. doi: 10.1186/s13020-018-0165-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13020-018-0165-1</ArticleId><ArticleId IdType="pmc">PMC5785906</ArticleId><ArticleId IdType="pubmed">29416556</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Yu Q., Peng L., Qin Y., Jing M., Huang D., Guo J., Xiao M., Chen M. Benefits and Safety of Chinese Herbal Medicine in Treating Psoriasis: An Overview of Systematic Reviews. Front. Pharmacol. 2021;12:1560. doi: 10.3389/fphar.2021.680172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.680172</ArticleId><ArticleId IdType="pmc">PMC8281221</ArticleId><ArticleId IdType="pubmed">34276371</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Xu B., Zhang Y., Duan Y., Gao R., He H., Li X., Li J. Efficacy and Safety of Traditional Chinese Medicine in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. Front. Pharmacol. 2021;12:1845. doi: 10.3389/fphar.2021.609213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.609213</ArticleId><ArticleId IdType="pmc">PMC8379002</ArticleId><ArticleId IdType="pubmed">34421581</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren J.-L., Zhang A.-H., Wang X.-J. Traditional Chinese medicine for COVID-19 treatment. Pharmacol. Res. 2020;155:104743. doi: 10.1016/j.phrs.2020.104743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104743</ArticleId><ArticleId IdType="pmc">PMC7128263</ArticleId><ArticleId IdType="pubmed">32145402</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y.-C., National Research Institute of Chinese Medicine, Ministry of Health and Welfare  Prescription Basis, Prescription and Basic Research of Taiwan Qingguan No. 1 (NRICM101) (2021)  [(accessed on 22 November 2022)].  Available online:  https://www.nricm.edu.tw/p/406-1000-6497,r51.php?Lang=en.</Citation></Reference><Reference><Citation>Tsai K.-C., Huang Y.-C., Liaw C.-C., Tsai C.-I., Chiou C.-T., Lin C.-J., Wei W.-C., Lin S.J.-S., Tseng Y.-H., Yeh K.-M., et al. A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study. Biomed. Pharmacother. 2020;133:111037. doi: 10.1016/j.biopha.2020.111037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.111037</ArticleId><ArticleId IdType="pmc">PMC7676327</ArticleId><ArticleId IdType="pubmed">33249281</ArticleId></ArticleIdList></Reference><Reference><Citation>MOHW. Ministry of Health and Welfare, National Research Institute of Chinese Medicine. 2022.  [(accessed on 22 November 2022)].  Available online:  https://www.nricm.edu.tw/p/406-1000-6789,r51.php?Lang=zh-tw.</Citation></Reference><Reference><Citation>Cheng Y.-D., Lu C., Hsu Y.-M., Tsai F.-J., Bau D.-T., Tsai S.-C., Cheng C.-C., Lin J.-J., Huang Y.-Y., Juan Y.-N., et al. In silico and in vitro studies of Taiwan Chingguan Yihau (NRICM101) on TNF-&#x3b1;/IL-1&#x3b2;-induced Human Lung Cells. BioMedicine. 2022;12:56&#x2013;71. doi: 10.37796/2211-8039.1378.</Citation><ArticleIdList><ArticleId IdType="doi">10.37796/2211-8039.1378</ArticleId><ArticleId IdType="pmc">PMC9629402</ArticleId><ArticleId IdType="pubmed">36381194</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Luzum J.A., Nicol M.R., Jacobson P.A. Pharmacogenomics of COVID-19 therapies. NPJ Genom. Med. 2020;5:35. doi: 10.1038/s41525-020-00143-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41525-020-00143-y</ArticleId><ArticleId IdType="pmc">PMC7435176</ArticleId><ArticleId IdType="pubmed">32864162</ArticleId></ArticleIdList></Reference><Reference><Citation>Quillet A., Saad C., Ferry G., Anouar Y., Vergne N., Lecroq T., Dubessy C. Improving Bioinformatics Prediction of microRNA Targets by Ranks Aggregation. Front. Genet. 2020;10:1330. doi: 10.3389/fgene.2019.01330.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2019.01330</ArticleId><ArticleId IdType="pmc">PMC6997536</ArticleId><ArticleId IdType="pubmed">32047509</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu M., Fan G., Xiao G., Wang T., Xu D., Gao J., Ge S., Li Q., Ma Y., Zhang H., et al. Traditional Chinese medicine in COVID-19. Acta Pharm. Sin. B. 2021;11:3337&#x2013;3363. doi: 10.1016/j.apsb.2021.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.09.008</ArticleId><ArticleId IdType="pmc">PMC8450055</ArticleId><ArticleId IdType="pubmed">34567957</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K., Zhang P., Zhang Z., Youn J.Y., Wang C., Zhang H., Cai H. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms. Pharmacol. Ther. 2021;225:107843. doi: 10.1016/j.pharmthera.2021.107843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2021.107843</ArticleId><ArticleId IdType="pmc">PMC8011334</ArticleId><ArticleId IdType="pubmed">33811957</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano T., Murakami M. COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome. Immunity. 2020;52:731&#x2013;733. doi: 10.1016/j.immuni.2020.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.003</ArticleId><ArticleId IdType="pmc">PMC7175868</ArticleId><ArticleId IdType="pubmed">32325025</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L.-P., Wang J., Xie R.-H., Pakhale S., Krewski D., Cameron D.W., Wen S.W. The Effects of Traditional Chinese Medicine as an Auxiliary Treatment for COVID-19: A Systematic Review and Meta-Analysis. J. Altern. Complement. Med. 2021;27:225&#x2013;237. doi: 10.1089/acm.2020.0310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2020.0310</ArticleId><ArticleId IdType="pubmed">33252246</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan A., Lahiri C., Rajendiran A., Shanmugham B. Computational analysis of protein interaction networks for infectious diseases. Briefings Bioinform. 2015;17:517&#x2013;526. doi: 10.1093/bib/bbv059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbv059</ArticleId><ArticleId IdType="pmc">PMC7110031</ArticleId><ArticleId IdType="pubmed">26261187</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama T., Kubli S.P., Yoshinaga S.K., Pfeffer K., Mak T.W. An aberrant STAT pathway is central to COVID-19. Cell Death Differ. 2020;27:3209&#x2013;3225. doi: 10.1038/s41418-020-00633-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-00633-7</ArticleId><ArticleId IdType="pmc">PMC7545020</ArticleId><ArticleId IdType="pubmed">33037393</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Jin X., Fan Q., Li C., Zhang M., Wang Y., Wu Q., Li J., Liu X., Wang S., et al. Deciphering the Active Compounds and Mechanisms of HSBDF for Treating ALI via Integrating Chemical Bioinformatics Analysis. Front. Pharmacol. 2022;13:879268. doi: 10.3389/fphar.2022.879268.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.879268</ArticleId><ArticleId IdType="pmc">PMC9201258</ArticleId><ArticleId IdType="pubmed">35721141</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Q., Du J., Li X., Zeng J., Tan B., Xu J., Lin W., Chen X.-L. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19. Drug Dev. Ind. Pharm. 2020;46:1345&#x2013;1353. doi: 10.1080/03639045.2020.1788070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03639045.2020.1788070</ArticleId><ArticleId IdType="pmc">PMC7441778</ArticleId><ArticleId IdType="pubmed">32643448</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.-F., Bai C., He F., Xie Y., Zhou H. Review on the potential action mechanisms of Chinese medicines in treating Coronavirus Disease 2019 (COVID-19) Pharmacol. Res. 2020;158:104939. doi: 10.1016/j.phrs.2020.104939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104939</ArticleId><ArticleId IdType="pmc">PMC7239792</ArticleId><ArticleId IdType="pubmed">32445956</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Lee H.J. Research Trend Visualization by MeSH Terms from PubMed. Int. J. Environ. Res. Public Health. 2018;15:1113. doi: 10.3390/ijerph15061113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph15061113</ArticleId><ArticleId IdType="pmc">PMC6025283</ArticleId><ArticleId IdType="pubmed">29848974</ArticleId></ArticleIdList></Reference><Reference><Citation>Schriml L.M., Munro J.B., Schor M., Olley D., McCracken C., Felix V., Baron J.A., Jackson R., Bello S.M., Bearer C., et al. The Human Disease Ontology 2022 update. Nucleic Acids Res. 2021;50:D1255&#x2013;D1261. doi: 10.1093/nar/gkab1063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1063</ArticleId><ArticleId IdType="pmc">PMC8728220</ArticleId><ArticleId IdType="pubmed">34755882</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqi H.K., Libby P., Ridker P.M. COVID-19&#x2014;A vascular disease. Trends Cardiovasc. Med. 2021;31:1&#x2013;5. doi: 10.1016/j.tcm.2020.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.10.005</ArticleId><ArticleId IdType="pmc">PMC7556303</ArticleId><ArticleId IdType="pubmed">33068723</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Li M., Wang M., Zhou Y., Chang J., Xian Y., Wang D., Mao L., Jin H., Hu B. Acute cerebrovascular disease following COVID-19: A single center, retrospective, observational study. Stroke Vasc. Neurol. 2020;5:279&#x2013;284. doi: 10.1136/svn-2020-000431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000431</ArticleId><ArticleId IdType="pmc">PMC7371480</ArticleId><ArticleId IdType="pubmed">32616524</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguila E.J.T., Cua I.H.Y., Fontanilla J.A.C., Yabut V.L.M., Causing M.F.P. Gastrointestinal Manifestations of COVID-19: Impact on Nutrition Practices. Nutr. Clin. Pract. 2020;35:800&#x2013;805. doi: 10.1002/ncp.10554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ncp.10554</ArticleId><ArticleId IdType="pmc">PMC7405319</ArticleId><ArticleId IdType="pubmed">32668037</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Mart&#xed;nez M.M., Boada C.C., Madera-Silva M.D., Mar&#xed;n W., Contreras M. COVID-19 y diabetes mellitus: Una relaci&#xf3;n bidireccional. Clin. Investig. Arterioscler. 2021;33:151&#x2013;157. doi: 10.1016/j.arteri.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arteri.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Farr R.J., Rootes C.L., Rowntree L.C., Nguyen T.H.O., Hensen L., Kedzierski L., Cheng A.C., Kedzierska K., Au G.G., Marsh G.A., et al. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog. 2021;17:e1009759. doi: 10.1371/journal.ppat.1009759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009759</ArticleId><ArticleId IdType="pmc">PMC8318295</ArticleId><ArticleId IdType="pubmed">34320031</ArticleId></ArticleIdList></Reference><Reference><Citation>Acu&#xf1;a S.M., Floeter-Winter L.M., Muxel S.M. MicroRNAs: Biological Regulators in Pathogen&#x2013;Host Interactions. Cells. 2020;9:113. doi: 10.3390/cells9010113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9010113</ArticleId><ArticleId IdType="pmc">PMC7016591</ArticleId><ArticleId IdType="pubmed">31906500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.-R., Chang C.-M., Yeh Y.-C., Huang C.-Y.F., Lin F.-M., Huang J.-T., Hsieh C.-C., Wang J.-R., Liu H.-S. Honeysuckle Aqueous Extracts Induced let-7a Suppress EV71 Replication and Pathogenesis In Vitro and In Vivo and Is Predicted to Inhibit SARS-CoV-2. Viruses. 2021;13:308. doi: 10.3390/v13020308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13020308</ArticleId><ArticleId IdType="pmc">PMC7920029</ArticleId><ArticleId IdType="pubmed">33669264</ArticleId></ArticleIdList></Reference><Reference><Citation>Fani M., Zandi M., Ebrahimi S., Soltani S., Abbasi S. The role of miRNAs in COVID-19 disease. Futur. Virol. 2021;16:301&#x2013;306. doi: 10.2217/fvl-2020-0389.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl-2020-0389</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis A.P., Wiegers T.C., Johnson R.J., Sciaky D., Wiegers J., Mattingly C.J. Comparative Toxicogenomics Database (CTD): Update 2021. Nucleic Acids Res. 2021;49:D1138&#x2013;D1143. doi: 10.1093/nar/gkaa891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa891</ArticleId><ArticleId IdType="pmc">PMC7779006</ArticleId><ArticleId IdType="pubmed">33068428</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Guo F., Wang Y., Li C., Zhang X., Li H., Diao L., Gu J., Wang W., Li D., et al. BATMAN-TCM: A Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine. Sci. Rep. 2016;6:21146. doi: 10.1038/srep21146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep21146</ArticleId><ArticleId IdType="pmc">PMC4754750</ArticleId><ArticleId IdType="pubmed">26879404</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.Y.-C. TCM Database@Taiwan: The World&#x2019;s Largest Traditional Chinese Medicine Database for Drug Screening In Silico. PLoS ONE. 2011;6:e15939. doi: 10.1371/journal.pone.0015939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015939</ArticleId><ArticleId IdType="pmc">PMC3017089</ArticleId><ArticleId IdType="pubmed">21253603</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelzer G., Rosen R., Plaschkes I., Zimmerman S., Twik M., Fishilevich S., Iny Stein T., Nudel R., Lieder I., Mazor Y., et al. The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analysis. Curr. Protoc. Bioinform. 2016;54:1&#x2013;30. doi: 10.1002/cpbi.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpbi.5</ArticleId><ArticleId IdType="pubmed">27322403</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Nastou K.C., Lyon D., Kirsch R., Pyysalo S., Doncheva N.T., Legeay M., Fang T., Bork P., et al. The STRING database in 2021: Customizable protein&#x2013;protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2020;49:D605&#x2013;D612. doi: 10.1093/nar/gkaa1074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1074</ArticleId><ArticleId IdType="pmc">PMC7779004</ArticleId><ArticleId IdType="pubmed">33237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge S.X., Jung D., Yao R. ShinyGO: A graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2019;36:2628&#x2013;2629. doi: 10.1093/bioinformatics/btz931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btz931</ArticleId><ArticleId IdType="pmc">PMC7178415</ArticleId><ArticleId IdType="pubmed">31882993</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Zhou B., Pache L., Chang M., Khodabakhshi A.H., Tanaseichuk O., Benner C., Chanda S.K. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1523. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software environment for integrated models of Biomolecular Interaction Networks. Genome Res. 2003;13:2498&#x2013;2504. doi: 10.1101/gr.1239303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.1239303</ArticleId><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Amahong K., Sun X., Lian X., Liu J., Sun H., Lou Y., Zhu F., Qiu Y. The miRNA: A small but powerful RNA for COVID-19. Briefings Bioinform. 2021;22:1137&#x2013;1149. doi: 10.1093/bib/bbab062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbab062</ArticleId><ArticleId IdType="pmc">PMC7989616</ArticleId><ArticleId IdType="pubmed">33675361</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>